Vanguard Group
OCUL icon

Vanguard Group’s Ocular Therapeutix OCUL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$77.9M Buy
8,392,175
+27,660
+0.3% +$257K ﹤0.01% 1933
2025
Q1
$61.3M Sell
8,364,515
-119,398
-1% -$875K ﹤0.01% 2008
2024
Q4
$72.5M Buy
8,483,913
+99,730
+1% +$852K ﹤0.01% 2004
2024
Q3
$72.9M Sell
8,384,183
-227,918
-3% -$1.98M ﹤0.01% 2025
2024
Q2
$58.9M Buy
8,612,101
+1,376,970
+19% +$9.42M ﹤0.01% 2082
2024
Q1
$65.8M Buy
7,235,131
+2,117,029
+41% +$19.3M ﹤0.01% 2052
2023
Q4
$22.8M Buy
5,118,102
+1,057,123
+26% +$4.71M ﹤0.01% 2535
2023
Q3
$12.8M Buy
4,060,979
+8,152
+0.2% +$25.6K ﹤0.01% 2741
2023
Q2
$20.9M Buy
4,052,827
+11,437
+0.3% +$59K ﹤0.01% 2572
2023
Q1
$21.3M Buy
4,041,390
+64,537
+2% +$340K ﹤0.01% 2561
2022
Q4
$11.2M Buy
3,976,853
+25,047
+0.6% +$70.4K ﹤0.01% 2903
2022
Q3
$16.4M Buy
3,951,806
+53,255
+1% +$221K ﹤0.01% 2717
2022
Q2
$15.7M Sell
3,898,551
-296,855
-7% -$1.19M ﹤0.01% 2766
2022
Q1
$20.8M Buy
4,195,406
+116,383
+3% +$576K ﹤0.01% 2752
2021
Q4
$28.4M Buy
4,079,023
+394,174
+11% +$2.75M ﹤0.01% 2655
2021
Q3
$36.8M Buy
3,684,849
+15,884
+0.4% +$159K ﹤0.01% 2527
2021
Q2
$52M Buy
3,668,965
+25,902
+0.7% +$367K ﹤0.01% 2354
2021
Q1
$59.8M Buy
3,643,063
+93,065
+3% +$1.53M ﹤0.01% 2218
2020
Q4
$73.5M Buy
3,549,998
+571,235
+19% +$11.8M ﹤0.01% 1997
2020
Q3
$22.7M Sell
2,978,763
-28,396
-0.9% -$216K ﹤0.01% 2397
2020
Q2
$25.1M Buy
3,007,159
+907,320
+43% +$7.56M ﹤0.01% 2309
2020
Q1
$10.4M Buy
2,099,839
+91,032
+5% +$451K ﹤0.01% 2605
2019
Q4
$7.93M Sell
2,008,807
-2,189
-0.1% -$8.65K ﹤0.01% 2966
2019
Q3
$6.11M Buy
2,010,996
+139,049
+7% +$423K ﹤0.01% 3060
2019
Q2
$8.24M Buy
1,871,947
+234,360
+14% +$1.03M ﹤0.01% 2971
2019
Q1
$6.5M Buy
1,637,587
+50,534
+3% +$201K ﹤0.01% 3037
2018
Q4
$6.32M Buy
1,587,053
+159,520
+11% +$635K ﹤0.01% 2985
2018
Q3
$9.82M Buy
1,427,533
+92,335
+7% +$635K ﹤0.01% 2930
2018
Q2
$9.01M Sell
1,335,198
-9,343
-0.7% -$63.1K ﹤0.01% 2956
2018
Q1
$8.75M Buy
1,344,541
+273,677
+26% +$1.78M ﹤0.01% 2882
2017
Q4
$4.77M Buy
1,070,864
+41,960
+4% +$187K ﹤0.01% 3154
2017
Q3
$6.36M Buy
1,028,904
+123,448
+14% +$763K ﹤0.01% 3017
2017
Q2
$8.39M Buy
905,456
+3,194
+0.4% +$29.6K ﹤0.01% 2859
2017
Q1
$8.37M Buy
902,262
+174,688
+24% +$1.62M ﹤0.01% 2840
2016
Q4
$6.09M Sell
727,574
-22,300
-3% -$187K ﹤0.01% 2973
2016
Q3
$5.15M Buy
749,874
+270,565
+56% +$1.86M ﹤0.01% 2989
2016
Q2
$2.37M Buy
479,309
+23,793
+5% +$118K ﹤0.01% 3322
2016
Q1
$4.4M Buy
455,516
+3,938
+0.9% +$38K ﹤0.01% 3032
2015
Q4
$4.23M Buy
451,578
+22,163
+5% +$208K ﹤0.01% 3064
2015
Q3
$6.04M Buy
429,415
+118,883
+38% +$1.67M ﹤0.01% 2881
2015
Q2
$6.53M Buy
310,532
+137,530
+79% +$2.89M ﹤0.01% 2880
2015
Q1
$7.26M Buy
173,002
+98,663
+133% +$4.14M ﹤0.01% 2804
2014
Q4
$1.75M Buy
74,339
+35,017
+89% +$824K ﹤0.01% 3333
2014
Q3
$588K Buy
+39,322
New +$588K ﹤0.01% 3674